<DOC>
	<DOC>NCT02164565</DOC>
	<brief_summary>The use of Tranexamic Acid (TXA) intravenously, to Reduce Blood Loss in proximal femur surgery.</brief_summary>
	<brief_title>The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery</brief_title>
	<detailed_description />
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients over 60, who came to the orthopedic department for proximal femur fracture surgery Sound judgment Known hypersensitivity to Tranexamic Acid or component solution provided Subarachnoid hemorrhage Acquired color blindness Myocardial infarction in 12 months before admission Unstable angina Known clotting disorders (Thromboembolic disease in the past, elongated PT and PTT, hypercoagulability), Kidney or liver failure Another situation prostate resection , pathologic fractures according to anamnesis or by imaging Oncology patients Patients on anticoagulation Patients undergoing vascular intervention ( coronary or peripheral ), which was inserted Supporter requires a Dual antiplatelet therapy</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>